Donate Now
  • What We're Working On
Understanding the Origins of Inflammation in Those with Rheumatoid Arthritis May Lead to New Treatments
Petri-Dish
Scientific Study Title:
Hematopoietic Stem and Progenitor Cells as Mediators of Trained Immunity in Rheumatoid Arthritis
Start Date:
  • October 2020
End Date:
  • September 2025
Research Category
Tags

Why do this research?

Reason For Research

Rheumatoid arthritis (RA) is an autoimmune disease that affects 1 out of every 100 adult Canadians (this represents 300,000 Canadians). Although anyone can get RA at any age, RA affects women two to three times more often than men. In RA, the immune system of the patient is activated leading to chronic inflammation and damage of joints but also other affected organs (e.g., lungs, heart, eyes, blood vessels). As a result, RA reduces patients’ quality of life and lifespan. The treatment of RA aims at suppressing inflammation. Despite current treatment options, some people with RA have ongoing inflammation. Those patients would benefit from new treatment approaches. Understanding the mechanisms that drive inflammation in RA is key to developing new treatment for RA patients.

What will be done?

Execution of Research

All cells from the immune system originate from ‘mother cells’ called hematopoietic stem and progenitor cells (HSPCs). In previous studies, we showed that HSPCs from people living with RA function differently than those from healthy people. This study focuses on understanding the causes of the RA-HSPC defects and how they affect the function of the immune system. Understanding of the role of HSPCs in RA may lead to new treatment approaches for people with RA.

In this study, we will examine blood samples from people newly diagnosed with RA and healthy people of same age and sex to address the following questions. In people with RA:

  • Do HSPCs increase inflammation?
  • Are the defects of HSPC transferred to the immune cells that the HPSCs generate?
  • Does RA treatment restore the defects of HSPCs?

How Can People Get Involved?

Involvement

Three groups with complementary expertise will conduct this work:

  • Dr. Nijnik’s team has a unique expertise in how HSPC develop immune cells and how to test this in animal models;
  • Dr. Langlais’ team are leaders in understanding how genes and proteins in cells are linked to their function;
  • Dr. Colmegna’s team has expertise in analyzing the function of RA-HSPC.

If you live in Montreal, Quebec, have newly diagnosed RA, are not yet treated and are interested in participating in this study, you can contact Dr. Colmegna who will provide you more details.

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More